Pharmacokinetics of nevirapine and lamivudine in patients with HIV-1 infection

Xpose—an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

E. Niclas Jonsson, Mats O. Karlsson · Computer Methods and Programs in Biomedicine · 1998 · 998 citations

Molecular Pharmacology, Pharmacokinetic Modeling, Xpose—an S-plus +8

Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter

Joseph J. Eron, Sharon L. Benoit, Joseph G. Jemsek et al. · New England Journal of Medicine · 1995 · 538 citations · Full text

High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus Infection

Diane V. Havlir, Sarah H. Cheeseman, Mark P. McLaughlin et al. · The Journal of Infectious Diseases · 1995 · 305 citations

High-dose Nevirapine, Pharmacotherapy, Antiviral Drug +17

Disposition and Biotransformation of the Antiretroviral Drug Nevirapine in Humans

Paul Riska, Michael Lamson, Thomas R. MacGregor et al. · Drug Metabolism and Disposition · 1999 · 221 citations

Drug Interactions in Patients Infected with Human Immunodeficiency Virus

Stephen C. Piscitelli, Charles Flexner, J R Minor et al. · Clinical Infectious Diseases · 1996 · 151 citations · Full text

Drug Interactions, Translational Medicine, Aids Commentary +13